van Veelen A, Veerman GDM, Verschueren MV, Gulikers JL, et al. Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. Int J Cancer 2023 Oct 15. doi: 10.1002/ijc.34742.
PMID: 37840304